PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 26 filers reported holding PSYCHEMEDICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 44,501 | $218,263 | 0.12% |
| Cannell Capital | 74,794 | $366,842 | 0.07% |
| SANTA MONICA PARTNERS LP | 20,000 | $98 | 0.07% |
| RBF Capital, LLC | 144,231 | $707,000 | 0.05% |
| CRAWFORD INVESTMENT COUNSEL INC | 257,795 | $1,264,405 | 0.03% |
| Ancora Advisors LLC | 70,916 | $348 | 0.01% |
| WEDBUSH SECURITIES INC | 30,928 | $152 | 0.01% |
| Renaissance Technologies | 290,463 | $1,425 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 35,206 | $173 | 0.00% |
| NORTHERN TRUST CORP | 17,030 | $83,527 | 0.00% |